Mr. Shane Madden reports

HYDREIGHT TECHNOLOGIES PARTNERS WITH RENOWNED ENDOCRINOLOGIST DR. FRANKLIN JOSEPH TO BRING GLOBALLY SUCCESSFUL WEIGHT LOSS BRAND TO THE U.S. VIA VSDHONE PLATFORM

Hydreight Technologies Inc. has formed a partnership with diabetes, obesity and weight-loss expert Dr. Franklin Joseph. Together, they will launch Dr. Frank's internationally acclaimed weight-loss methodology, Dr. Frank's Method, across the United States via Hydreight's innovative VSDHOne platform. This high-impact collaboration is poised to capture significant market share within the booming GLP-1 weight loss and telehealth markets in North America.

Dr. Frank: a globally recognized authority in diabetes and obesity treatment

Dr. Franklin Joseph is a consultant physician in endocrinology, diabetes and internal medicine at the Countess of Chester Hospital in the United Kingdom. He served as associate medical director and clinical director of a regional Tier 3/Tier 4 bariatric service, which he helped build to serve a population of over 500,000 people.

He has led award-winning integrated diabetes programs, chaired the West Cheshire Diabetes Network, and held a national leadership role with the Royal College of Physicians' Future Hospital Program. He is currently a visiting professor at the University of Chester Medical School.

Dr. Frank has served as a principal investigator in global clinical trials studying GLP-1 receptor agonist therapies -- participating in programs such as Scale, Pioneer, Step and Redefine. Through this work, he has collaborated with leading pharmaceutical companies including Eli Lilly and Novo Nordisk, helping bring GLP-1 therapies from the clinical stage to front-line care through innovative service delivery models.

His brand, Dr. Frank's Method, is highly trusted across the United Kingdom, and is now expanding internationally to Australia, New Zealand, Hong Kong and Canada. The U.S. launch via Hydreight represents a pivotal milestone in the brand's international expansion.

Dr. Frank's Method: proven, scalable and patient-centred

With over 500,000 global patients served, Dr. Frank's approach combines evidence-based pharmacotherapy with expert medical oversight and holistic lifestyle support. Core elements of the program include:

• Branded GLP-1 medications (that is, Mounjaro, Wegovy and Rybelsus);
• Access to specialist weight-loss nurses for clinical support;
• Tailored nutritional, exercise and behavioural strategies.

The result: strong clinical outcomes, exceptional patient retention and consistent global demand.

Strategic rollout via Hydreight's VSDHOne platform

Under this partnership, Dr. Frank's trusted brand and clinical model will be seamlessly integrated into Hydreight's VSDHOne platform -- a compliant, scalable, direct-to-consumer telehealth solution.

Key partnership terms:

• Hydreight will waive platform fees;
• Dr. Frank has committed to a monthly United States marketing spend;
• The collaboration is structured on a 50/50 profit-sharing basis.

Together, they will launch a fully integrated, nationwide direct-to-consumer (D2C) weight-loss solution, combining Dr. Frank's clinical brand equity with Hydreight's fully compliant, scalable platform, and national nurse and doctor network.

Hydreight's chief executive officer, Shane Madden, commented: "We're extremely proud to partner with Dr. Frank -- a globally recognized leader who has literally shaped the GLP-1 weight-loss revolution. By bringing his proven methodology and internationally successful brand to our advanced telehealth platform, VSDHOne, we're creating a powerful solution perfectly positioned for rapid adoption in the expansive and underserved U.S. weight-loss market."

Dr. Joseph added: "The collaboration with Hydreight and their VSDHOne platform is a natural extension of my life's work in advancing patient-centred, effective obesity treatments. This partnership combines my globally proven weight-loss methodology with Hydreight's robust capability for nationwide, compliant, scalable telehealth delivery. Together, we're bringing a new standard of personalized obesity management and medical excellence to millions of patients across North America."

Unlocking the U.S. weight-loss market

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than two in five adults (42.4 per cent) in the United States have obesity. GLP-1 medications have emerged as a pivotal treatment, driving record demand.

The global weight-loss market is projected to exceed $400-billion by 2030 (Facts & Factors), while Medicaid data indicates that GLP-1 prescriptions increased by over 400 per cent, with gross spending rising by more than 500 per cent during this period.

Through this partnership, Hydreight is poised to become a key player in delivering medically backed GLP-1 solutions at scale-powered by VSDHOne.

"Dr. Frank's track record in the GLP-1 space is widely recognized," said Shane Madden, chief executive officer of Hydreight. "By combining his clinical excellence and brand trust with our compliant platform and national reach, we're bringing a proven weight-loss solution to millions of Americans who need it."

"Hydreight is the perfect U.S. partner for our next chapter," added Dr. Franklin Joseph. "Together, we're removing barriers to care, scaling personalized weight-loss treatment and empowering patients to transform their lives."

Strengthening Hydreight's market leadership

This partnership is a major milestone in Hydreight's strategy to lead the direct-to-consumer, telehealth-enabled health care evolution. With over 400 VSDHOne licences sold and a national network of providers, Hydreight continues to expand in high-growth sectors like:

• GLP-1 weight loss;
• Anti-aging and longevity (TRT, NAD+, peptides);
• Hair loss and sexual wellness;
• At-home diagnostic testing.

About Hydreight Technologies Inc.

Hydreight Technologies is building one of the largest mobile clinic network in the United States. Its proprietary, fully integrated platform hosts a network of over 3,000 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enables licensed health care professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a United States-certified e-script and telemedicine provider network.

We seek Safe Harbor.